trending Market Intelligence /marketintelligence/en/news-insights/trending/m0I5iK9BaRepkIDDb-IlVw2 content esgSubNav
In This List

UniQure announces $200M public offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


UniQure announces $200M public offering

uniQure NV started an underwritten public offering of its ordinary shares worth $200 million.

The Amsterdam-based biotechnology company, which develops and markets gene therapies, also plans to give underwriters a 30-day option to purchase additional ordinary shares worth $30 million.

Goldman Sachs & Co. LLC and SVB Leerink are acting as joint book-running managers, Stifel is acting as book-running manager while Cantor Fitzgerald & Co. and SunTrust Robinson Humphrey are co-lead managers. H.C. Wainwright & Co. is co-manager for the offering.